Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies

Last updated: November 8, 2023
Sponsor: Boston Children's Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Eye Disorders/infections

Vision Loss

Williams Syndrome

Treatment

N/A

Clinical Study ID

NCT03059420
05-03-036R
R01EY015298
  • Ages > 1
  • All Genders

Study Summary

The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • The Engle Lab is very interested in enrolling individuals with congenital conditionsrelated to eye movement, cranial nerve and brainstem-based dysfunction, often broadlyreferred to as congenital cranial dysinnervation disorders (CCDDs).

Exclusion

Exclusion Criteria:

  • Individuals with cranial nerve disorders associated with known disorders, such asSaethre-Chotzen associated with established genetic mutations, or acquired conditionsincluding trauma, stroke, tumor or spinal cord injuries.

Study Design

Total Participants: 20000
Study Start date:
February 01, 2004
Estimated Completion Date:
January 31, 2027

Study Description

If left untreated or unrecognized, strabismus or misalignment of the eyes, can impair the development of normal vision and is recognized to be an inherited trait in some families. The Engle Lab has investigated the genetics of complex and common strabismus and eyelid movement disorders for over 10 years and the lab's interests have expanded to include Congenital Cranial Dysinnervation Disorders (CCDDs) which are neurological disorders affecting one or more of the 12 cranial nerves. Cranial nerves control bodily functions such as movement of the eyes, transmission of visual information, smell, facial sensation, facial expression, blinking, hearing, balance, taste, chewing and swallowing.

Based on genetic studies on individuals with eye movement and eyelid disorders, the lab learned that some individuals have additional ocular defects, vascular, limb and other abnormalities. In addition, in some families relatives who carry the gene mutation may manifest the familial syndrome by having only some additional features but NOT the oculomotility disorder. Therefore, to gain greater understanding of the spectrum of the disorders being investigated, we may also enroll individuals without eye movement or lid defects who have symptoms associated with mutations in congenital cranial dysinnervation disorder (CCDD) genes.

Connect with a study center

  • Boston Children's Hospital

    Boston, Massachusetts 02115
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.